简介：　　摘要：目的  观察酪酸梭菌活菌散在治疗小儿消化不良性腹泻患儿中的应用疗效。方法  选取 2017年 8月～ 2019年 6月 我院收治的小儿消化不良性腹泻患儿84例，按随机数字表法分为两组，各 42例。观察组给予酪酸梭菌活菌散药物联合醒脾养儿颗粒医治，对照组单独给予醒脾养儿颗粒药物医治，比较两组总有效率、症状改善时间、不良反应发生率。结果  治疗后，观察组总有效率明显高于对照组（ P<0.05）。观察组患儿腹泻、腹胀、腹痛消失时间、大便性状改变时间均短于对照组（ P<0.05） ;观察组患儿大便次数小于对照组（ P<0.05） ;观察组用药后不良反应发生率为 7.14%，低于对照组的 16.67%，差异有统计学意义（ P<0.05）。结论  在小儿消化不良性腹泻患儿中给予酪酸梭菌活菌散联合醒脾养儿颗粒医治效果较好，改善腹泻症状，用药安全性较高。  　　关键词：酪酸梭菌活菌散 ;小儿消化不良性腹泻 ;醒脾养儿颗粒   　 Abstract: Objective To observe the effect of Clostridium butyricum powder in the treatment of children with dyspepsia diarrhea. Methods from August 2017 to June 2019, 84 children with dyspepsia diarrhea were selected and divided into two groups according to the random number table, 42 cases in each group. The observation group was treated with Clostridium butyricum powder combined with Xingpi Yanger granules, while the control group was treated with Xingpi Yanger granules alone. The total effective rate, symptom improvement time and adverse reaction rate of the two groups were compared. Results after treatment, the total effective rate of the observation group was significantly higher than that of the control group (P < 0.05). The time of diarrhea, abdominal distention, disappearance of abdominal pain and change of stool characteristics in the observation group were shorter than those in the control group (P < 0.05); the frequency of stool in the observation group was shorter than that in the control group (P < 0.05); the incidence of adverse reactions in the observation group was 7.14%, lower than 16.67% in the control group (P < 0.05). Conclusion: the curative effect of Clostridium butyricum combined with Xingpi Yanger granule is better in children with dyspepsia diarrhea. It can improve the symptoms of diarrhea and has a high safety.

简介：【摘要】目的 探究强化感染护理干预对降低重症监护病房（ICU）患者多重耐药菌感染的价值。方法 回顾性分析2019年8月——2021年7月于本院就诊的96例ICU患者，依据护理方式的不同将其分为参考组（n=48）、观察组（n=48）。参考组予以常规抗感染护理，观察组予以强化感染护理。对比两组干预后卫生指标（手卫生、个人防护用品、医疗废物处理）合格率；对比两组多重耐药菌感染率及转归情况。结果 观察组手卫生、个人防护用品、医疗废物处理合格率均高于参考组，差异具有统计学意义（P＜0.05）。观察组多重耐药菌感染率低于参考组，差异具有统计学意义（

简介：摘要目的探讨脑活素、1，6二磷酸果糖联合治疗新生儿缺氧缺血性脑病的疗效。方法对50例（HTE）新生儿随机分为两组，观察组25例采用脑活素、1，6二磷酸果糖联合治疗，对照组25例只使用脑活素治疗。观察两组治疗前后新生儿神经行为评分（NBNA评分）变化和临床疗效比较。结果治疗后观察组NBNA评分高于对照组（P＜0.01），总有效率比较差异有显著性（P＜0.05）；结论脑活素1，6二磷酸果糖联合治疗新生儿（HTE）疗效满意，无明显不良反应。